Matches in DBpedia 2016-04 for { ?s ?p "Aplaviroc (INN, codenamed AK602 and GSK-873140) is a CCR5 entry inhibitor that belongs to a class of 2,5-diketopiperazines developed for the treatment of HIV infection. It was developed by GlaxoSmithKline.In October 2005, all studies of aplaviroc were discontinued due to liver toxicity concerns."@en }
Showing triples 1 to 2 of
2
with 100 triples per page.
- Aplaviroc comment "Aplaviroc (INN, codenamed AK602 and GSK-873140) is a CCR5 entry inhibitor that belongs to a class of 2,5-diketopiperazines developed for the treatment of HIV infection. It was developed by GlaxoSmithKline.In October 2005, all studies of aplaviroc were discontinued due to liver toxicity concerns.".
- Q4779956 comment "Aplaviroc (INN, codenamed AK602 and GSK-873140) is a CCR5 entry inhibitor that belongs to a class of 2,5-diketopiperazines developed for the treatment of HIV infection. It was developed by GlaxoSmithKline.In October 2005, all studies of aplaviroc were discontinued due to liver toxicity concerns.".